GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invuity Inc (NAS:IVTY) » Definitions » Return-on-Tangible-Equity

Invuity (Invuity) Return-on-Tangible-Equity : -555.30% (As of Jun. 2018)


View and export this data going back to 2015. Start your Free Trial

What is Invuity Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Invuity's annualized net income for the quarter that ended in Jun. 2018 was $-35.80 Mil. Invuity's average shareholder tangible equity for the quarter that ended in Jun. 2018 was $6.45 Mil. Therefore, Invuity's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2018 was -555.30%.

The historical rank and industry rank for Invuity's Return-on-Tangible-Equity or its related term are showing as below:

IVTY's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.87
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Invuity Return-on-Tangible-Equity Historical Data

The historical data trend for Invuity's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invuity Return-on-Tangible-Equity Chart

Invuity Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17
Return-on-Tangible-Equity
- - - -105.76 -237.71

Invuity Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -236.98 -391.19 -1,306.06 -923.46 -555.30

Competitive Comparison of Invuity's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Invuity's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invuity's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invuity's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Invuity's Return-on-Tangible-Equity falls into.



Invuity Return-on-Tangible-Equity Calculation

Invuity's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2017 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2017 )  (A: Dec. 2016 )(A: Dec. 2017 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2017 )  (A: Dec. 2016 )(A: Dec. 2017 )
=-39.918/( (34.448+-0.862 )/ 2 )
=-39.918/16.793
=-237.71 %

Invuity's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2018 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=-35.8/( (10.562+2.332)/ 2 )
=-35.8/6.447
=-555.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2018) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Invuity  (NAS:IVTY) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Invuity Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Invuity's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Invuity (Invuity) Business Description

Traded in Other Exchanges
N/A
Address
Invuity Inc is a United States-based commercial-stage medical technology company which utilizes its proprietary Intelligent Photonics technology to develop single-use and reusable illuminated surgical devices. It provides surgeons with illumination and direct visualization of surgical cavities during open minimally invasive and minimal access procedures. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System, Waveguide XT System, among others. It sells directly to hospitals, surgeons typically drive the purchasing decision.
Executives
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Eric W Roberts director VALENCE LIFE SCIENCES LLC, 500 PARK AVENUE 9TH FLOOR, NEW YORK NY 10022
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Randall A Lipps director 1101 EAST MEADOW DR, PALO ALTO CA 94303
Dan Wolterman director 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
James H Mackaness officer: Chief Financial Officer 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Reza Zadno director 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Douglas A Pepper 10 percent owner C/O INTERWEST PARTNERS, 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Philip T Gianos 10 percent owner 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Keval Desai 10 percent owner 467 FIRST STREET, SUITE 201, LOS ALTOS X1 94022
Interwest Partners X Lp 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022